Sign in
Development and preliminary evaluation of the Conventional Medicine Disclosure Index
Journal article   Peer reviewed

Development and preliminary evaluation of the Conventional Medicine Disclosure Index

Erica McIntyre, Hope Foley, Joanna Harnett, Jon Adams and Amie Steel
Research in social and administrative pharmacy, Vol.17(10), pp.1791-1799
10/2021
PMID: 33558156

Metrics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Abstract

Communication barriers Complementary medicine Disclosure Instrument development Patient communication Pharmaceutical dugs
Non-disclosure of conventional medicine use to complementary medicine health professionals may result in patient harm. Currently, no standardised validated instrument is available to measure reasons for conventional medicine disclosure or non-disclosure. The aim of this study was to develop and evaluate a multidimensional index for identifying reasons for conventional medicine disclosure and non-disclosure by patients.

Details